High Co-expression of PDL-1/PD-1, CD 8+and CD45RO+in Tumor-infiltrating lymphocytes (TILs) with EMT Activation Correlates with Aggressive Behavior and Poor Prognosis in High-Grade Pulmonary Neuroendocrine Tumors

被引：0
|
作者：
Prieto, Tabatha [1 ]
Martins, Vanessa [1 ]
Capelozzi, Vera Luiza [1 ]
da Silva, Eduardo C. [2 ]
机构：
[1] Univ Sao Paulo, Fac Med, Sao Paulo, Brazil
[2] Barretos Canc Hosp, Barretos, SP, Brazil
来源：
MODERN PATHOLOGY | 2018年 / 31卷
关键词：
D O I：
暂无
中图分类号：
R36 [病理学];
学科分类号：
100104 ;
摘要：
2085
引用
收藏
页码：746 / 746
页数：1
相关论文
共 15 条
  • [1] High Co-expression of PDL-1/PD-1, CD 8+and CD45RO+in Tumor-infiltrating lymphocytes (TILs) with EMT Activation Correlates with Aggressive Behavior and Poor Prognosis in High-Grade Pulmonary Neuroendocrine Tumors
    Prieto, Tabatha
    Martins, Vanessa
    Capelozzi, Vera Luiza
    da Silva, Eduardo C.
    LABORATORY INVESTIGATION, 2018, 98 : 746 - 746
  • [2] Composite score of PD-1+CD8+ tumor-infiltrating lymphocytes and CD57+CD8+ tumor ascites lymphocytes is associated with prognosis and tumor immune microenvironment of patients with advanced high-grade serous ovarian cancer
    He, Tianhui
    Zhang, Jie
    Zeng, Lin
    Yin, Zhongnan
    Yu, Bo
    Zhang, Xi
    Yang, Xiaoxue
    Shang, Chunliang
    Xue, Lixiang
    Guo, Hongyan
    CHINESE JOURNAL OF CANCER RESEARCH, 2025, 37 (01)
  • [3] Programmed death ligand-1 and CD8 tumor-infiltrating lymphocytes (TILs) as prognostic predictors in ovarian high-grade serous carcinoma (HGSC)
    Farrag, Mayada Saad
    Abdelwahab, Khaled
    Farrag, Nesrine Saad
    Elrefaie, Waleed Elsayed
    Emarah, Ziad
    JOURNAL OF THE EGYPTIAN NATIONAL CANCER INSTITUTE, 2021, 33 (01)
  • [4] Programmed death ligand-1 and CD8 tumor-infiltrating lymphocytes (TILs) as prognostic predictors in ovarian high-grade serous carcinoma (HGSC)
    Mayada Saad Farrag
    Khaled Abdelwahab
    Nesrine Saad Farrag
    Waleed Elsayed Elrefaie
    Ziad Emarah
    Journal of the Egyptian National Cancer Institute, 33
  • [5] Discordance of PD-L1 expression in primary and metastatic ovarian high-grade serous carcinoma and its correlation with CD8 + tumor-infiltrating lymphocytes and patient prognosis
    Tao Zhang
    Xin Zhou
    Xiaofei Zhang
    Shuang Niu
    Hao Chen
    Feng Zhou
    Virchows Archiv, 2023, 482 : 755 - 766
  • [6] Increased co-expression of 4-1BB with PD-1 on CD8+tumor-infiltrating lymphocytes is associated with improved prognosis and immunotherapy response in cervical cancer
    Zhu, Xiaonan
    Feng, Yaning
    Fan, Peiwen
    Dong, Danning
    Yuan, Jianlin
    Chang, Cheng
    Wang, Ruozheng
    FRONTIERS IN ONCOLOGY, 2024, 14
  • [7] A High PD-L1 Expression in Non-Small Cell Lung Cancer Correlates with Expression of SPOP and CD8 Tumor-Infiltrating Lymphocytes
    Inoue, M.
    Yoshida, J.
    Oka, S.
    Honda, Y.
    Chikaishi, Y.
    Yasuda, D.
    JOURNAL OF THORACIC ONCOLOGY, 2019, 14 (10) : S461 - S461
  • [8] PD-L1 Expression and CD8+ Tumor-infiltrating Lymphocytes in Different Types of Tubo-ovarian Carcinoma and Their Prognostic Value in High-grade Serous Carcinoma
    Chen, Hao
    Molberg, Kyle
    Strickland, Amanda L.
    Castrillon, Diego H.
    Carrick, Kelley
    Jiang, Qingping
    Niu, Shuang
    Rivera-Colon, Glorimar
    Gwin, Katja
    Hinson, Stacy
    Lea, Jayanthi
    Miller, David S.
    Zheng, Wenxin
    Lucas, Elena
    AMERICAN JOURNAL OF SURGICAL PATHOLOGY, 2020, 44 (08) : 1050 - 1060
  • [9] Discordance of PD-L1 expression in primary and metastatic ovarian high-grade serous carcinoma and its correlation with CD8+tumor-infiltrating lymphocytes and patient prognosis
    Zhang, Tao
    Zhou, Xin
    Zhang, Xiaofei
    Niu, Shuang
    Chen, Hao
    Zhou, Feng
    VIRCHOWS ARCHIV, 2023, 482 (04) : 755 - 766
  • [10] High tumoral PD-L1 expression and low PD-1+ or CD8+ tumor-infiltrating lymphocytes are predictive of a poor prognosis in primary diffuse large B-cell lymphoma of the central nervous system
    Kim, Sehui
    Nam, Soo Jeong
    Park, Changhee
    Kwon, Dohee
    Yim, Jeemin
    Song, Seung Geun
    Ock, Chan-Young
    Kim, Young A.
    Park, Sung Hye
    Kim, Tae Min
    Jeon, Yoon Kyung
    ONCOIMMUNOLOGY, 2019, 8 (09):
12